key: cord-0931483-pcc1v05x authors: Husser, Daniela; Hohenstein, Sven; Pellissier, Vincent; König, Sebastian; Ueberham, Laura; Hindricks, Gerhard; Meier-Hellmann, Andreas; Kuhlen, Ralf; Bollmann, Andreas title: Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic date: 2021-04-01 journal: Thromb Res DOI: 10.1016/j.thromres.2021.03.029 sha: 0a891f2fbd4b3fbdfcd96194c68db9437632ea47 doc_id: 931483 cord_uid: pcc1v05x nan To the Editor: Covid-19 infections are associated with a high prevalence of venous thromboembolism, particularly pulmonary embolism. 1 In this respect, it is with great interest that we have followed the discussion in this journal evolving around the emergence of different phenotypes of Covid-19-associated thromboembolic disease, i.e. acute pulmonary embolism vs pulmonary thrombosis, different phenotypes of in situ thrombosis and a rising incidence of hospitalizations for pulmonary embolism in England. [2] [3] [4] [5] The Helios hospital group is the largest hospital network in Germany serving about 7% of the German population. We have established a continuous surveillance program to monitor and report the effects of the Covid-19 pandemic on hospital admissions, resource use and outcomes. 6-10 With this correspondence, we wish to complement this discussion by providing hospitalization, treatment and in-hospital outcome data for pulmonary embolism during the 2020 Covid-19 pandemic and a corresponding 2016 -2019 control period. We performed a retrospective analysis of claims data of Helios hospitals in Germany. Consecutive cases with a hospital admission between January 1 and December 15, 2020 (study period) were analyzed and compared to a corresponding period covering the same As previously reported for other emergent medical conditions, there was a hospitalization By analyzing claims data of the German-wide Helios hospital network, we have identified an increase in cases with pulmonary embolism since early May 2020 compared to corresponding periods in 2016 -2019. This supports similar observations made in England. 5 Interestingly, there was a slight shift in patient characteristics with respect to age and sex distribution, and less contributing factors such as coagulopathy and metastatic cancer. Although overall comorbidity burden was almost identical between cohorts, in-hospital treatments and outcomes were suggestive of less severe disease. As in a comparable study in England, 5 only a minority of cases were associated with PCR-confirmed Covid-19 but this does not rule out preceding or undetected SARS-CoV-2 infection. There are several possible, non-exclusive explanations. For instance, it has been reported that Covid-19 associated pulmonary emboli are more likely to be located in the peripheral lung segments and are less extensive resulting in less frequent and severe right heart dysfunction compared to those in patients without Covid-19 pneumonia. 2 The existence of in situ pulmonary thrombosis as one additional mechanism in patients with Covid-19 has been suggested by the absence of deep venous thrombosis, the higher incidence of pulmonary embolism but not venous thrombosis in patients with Covid-19 compared to those without Covid-19, and pathologic findings of thrombosis within the pulmonary arteries in the absence of venous thrombosis in autopsies. 2-4 While the in-hospital course with reduced intensive care utilization, mechanical ventilation, length of stay and in-hospital mortality suggests a milder disease, the increased incidence of hospitalizations for pulmonary embolism is of special concern and could also be associated with preceding Covid-19 infections. 11 In fact, pulmonary embolism has been identified as reason for readmission after a Covid-19 hospitalization in 0.6 % of patients. 12, 13 Although this event rate seems rather low, the magnitude of Covid-19 infections worldwide may result in a substantial number of effected individuals. Alternatively or additionally, the raised awareness of respiratory symptoms that overlap between pulmonary embolism and Covid-19 such as cough or shortness of breath 2 may have prompted more hospital admissions. In addition, change in hospital protocols for the use of contrast-enhanced computed tomography in suspected Covid-19 cases may have detected incidental pulmonary embolism more frequently. Moreover, less mobility and the heat wave in 2020 may have contributed. Finally, changes in population-at-risk characteristics and catchment areas of the hospitals over time as well as more frequent diagnosis of low-risk embolism due to more sensitive tests cannot be ruled out. Although, the results of our and the study from England are comparable, the magnitude of the hospitalization increase was higher in England most likely due to lower baseline rate. How this is impacted by coding regimen and the use of different ICD-10 versions is unknown although a large code overlap (e.g. I26) exists. If the increased incidence of hospitalizations for pulmonary embolism is a signal for a rising incidence of this condition in the public, this could at least in part explain the observed excess mortality in Germany between late July and mid October 2020 not related with Covid-19 cases. 14 This finding requires immediate attention, close surveillance and further studies. Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Covid-19 and thrombotic complications: Pulmonary thrombosis rather than embolism? In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network Cumulative hospitalization deficit for cardiovascular disorders in Germany during the Covid-19 pandemic Inhospital mortality in heart failure in Germany during the Covid-19 pandemic. ESC Heart Fail Inhospital care in acute heart failure during the Covid-19 pandemic: insights from the Germanwide Helios hospital network Decreased incidence of oncology admissions in 75 Helios hospitals in Germany during the Covid-19 pandemic Pulmonary thrombosis in Covid-19: before, during and after hospital admission Assessment of thirty-day readmission rate, timing, causes, and predictors after hospitalization with Covid-19 Puerta de Hierro Hospital Admission Study Group. Hospital readmissions of discharged patients with Covid-19 Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just Covid-19?